Logo Logo
Switch Language to German
Mashima, Kyoko; Ito, Daisuke; Kameyama, Masashi; Osada, Takashi; Tabuchi, Hajime; Nihei, Yoshihiro; Yoshizaki, Takahito; Noguchi, Eri; Tanikawa, Mariko; Iizuka, Takashi; Date, Yugaku; Ogata, Yuji; Nakahara, Tadaki; Iwabuchi, Yu; Jinzaki, Masahiro; Murakami, Koji; Suzuki, Norihiro (2017): Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia. In: European Neurology, Vol. 77, No. 43256: pp. 231-237
Full text not available from 'Open Access LMU'.


Background: Most cases of dementia with Lewy bodies (DLB) show Alzheimer's disease pathology-like senile plaques and neurofibrillary tangles. Several studies have also revealed a high prevalence of positive amyloid imaging with positron emission tomography (PET) in DLB and moderate prevalence in Parkinson's disease (PD) with dementia. However, it remains unclear in PD without dementia as to when the brain beta amyloid (A beta) burden begins and progresses. Our study aimed to determine the prevalence of A beta deposition in PD without dementia using amyloid PET. Methods: This was a cross-sectional study on 33 patients with PD without dementia, of whom 21 had normal cognition and 12 met the criteria for PD-mild cognitive impairment. All subjects underwent neuropsychological assessment and [F-18] florbetaben (FBB) PET. Results: All subjects had Lewy body-related disorders, displaying a significantly reduced myocardial [I-123] metaiodobenzylguanidine uptake. The cortical FBB-binding pattern in all subjects, including APOE e4 carriers, suggested negative A beta deposition. Conclusion: Patients with PD without dementia exhibit an extremely low prevalence of A beta positivity compared with those reported in cognitively normal elderly controls. Further longitudinal imaging studies and long-term follow-up are needed;however, our findings provide novel insights for understanding A beta metabolism in PD. (C) 2017 S. Karger AG, Basel